Myra W. Popejoy

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller et al. · Clinical Infectious Diseases · 2015 · 400 citations · Full text

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> : a pooled analysis of Phase 3 clinical trials

Myra W. Popejoy, David L. Paterson, Daniel Cloutier et al. · Journal of Antimicrobial Chemotherapy · 2016 · 115 citations · Full text

A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Richard G. Wunderink, Antoine Roquilly, Martin A. Croce et al. · Clinical Infectious Diseases · 2021 · 54 citations · Full text

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia

Antonio Arrieta, John S. Bradley, Myra W. Popejoy et al. · The Pediatric Infectious Disease Journal · 2018 · 52 citations

Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study

Benjamin Miller, Myra W. Popejoy, Ellie Hershberger et al. · Antimicrobial Agents and Chemotherapy · 2016 · 35 citations · Full text